ChemSpider 2D Image | Darapladib | C36H38F4N4O2S

Darapladib

  • Molecular FormulaC36H38F4N4O2S
  • Average mass666.771 Da
  • Monoisotopic mass666.265137 Da
  • ChemSpider ID8115230

More details:



Featured data source



Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1H-Cyclopenta[d]pyrimidine-1-acetamide, N-[2-(diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]- [ACD/Index Name]
356057-34-6 [RN]
N-[2-(diethylamino)ethyl]-2-(2-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxo-1H,4H,5H,6H,7H-cyclopenta[d]pyrimidin-1-yl)-N-{[4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl]methyl}acetamide
N-[2-(Diethylamino)ethyl]-2-{2-[(4-fluorbenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[4'-(trifluormethyl)-4-biphenylyl]methyl}acetamid [German] [ACD/IUPAC Name]
N-[2-(Diethylamino)ethyl]-2-{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[4'-(trifluoromethyl)-4-biphenylyl]methyl}acetamide [ACD/IUPAC Name]
N-[2-(Diéthylamino)éthyl]-2-{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tétrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[4'-(trifluorométhyl)-4-biphénylyl]méthyl}acétamide [French] [ACD/IUPAC Name]
UI1U1MYH09
[356057-34-6] [RN]
1-[[[N-[2-(Diethylamino)ethyl]-N-[4-[4-(trifluoromethyl)phenyl]benzyl]amino]carbonyl]methyl]-2-(4-fluorobenzylthio)-5,6-trimethylenepyrimidin-4-one
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

8703 [DBID]
SB-480848 [DBID]
D03650 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      Darapladib is a selective and orally active inhibitor of Lp-PLA2 (IC50= 270 pM) MedChem Express
      Darapladib is a selective and orally active inhibitor of Lp-PLA2 (IC50= 270 pM) ; IC50 value: 270 pM; Target: Lp-PLA2; Darapladib, is a novel inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme that may link lipid metabolism with inflammation, leading to the increased stability of atherosclerotic plaques present in the major arteries. MedChem Express HY-10521
      Darapladib is a selective and orally active inhibitor of Lp-PLA2 (IC50= 270 pM) ;IC50 value: 270 pM;Target: Lp-PLA2Darapladib, is a novel inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme that may link lipid metabolism with inflammation, leading to the increased stability of atherosclerotic plaques present in the major arteries. Darapladib is being studied as a possible add-on treatment for atherosclerosis. MedChem Express HY-10521
      Others MedChem Express HY-10521
      Phospholipase MedChem Express HY-10521

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.3±0.1 g/cm3
Boiling Point: 741.0±70.0 °C at 760 mmHg
Vapour Pressure: 0.0±2.4 mmHg at 25°C
Enthalpy of Vaporization: 108.1±3.0 kJ/mol
Flash Point: 401.9±35.7 °C
Index of Refraction: 1.594
Molar Refractivity: 179.8±0.5 cm3
#H bond acceptors: 6
#H bond donors: 0
#Freely Rotating Bonds: 14
#Rule of 5 Violations: 2
ACD/LogP: 8.27
ACD/LogD (pH 5.5): 4.24
ACD/BCF (pH 5.5): 194.80
ACD/KOC (pH 5.5): 222.67
ACD/LogD (pH 7.4): 5.65
ACD/BCF (pH 7.4): 4990.67
ACD/KOC (pH 7.4): 5704.60
Polar Surface Area: 82 Å2
Polarizability: 71.3±0.5 10-24cm3
Surface Tension: 42.7±7.0 dyne/cm
Molar Volume: 529.6±7.0 cm3

Click to predict properties on the Chemicalize site






Advertisement